Molecular therapy set to protect at-risk patients against heart attack and stroke
Friday, March 31, 2017 - 20:01
in Health & Medicine
Even a single dose of a specific ribonucleic acid molecule, known as a small interfering RNA (siRNA), offers patients at high risk of cardiovascular disease long-lasting protection against high LDL cholesterol -- one of the main risk factors for heart attack and stroke -- conclude researchers.